Genmab A/S (GMAB.CO)
3,719.00 DKK +0.57%
Genmab A/S rose 0.57% in the latest session, at 3,719.00 DKK. By market cap it is number 2 of the 9 health care stocks on the C25 heatmap. Its trailing P/E of 45.9 is above the median of those peers (31.9). The price is 5.8% below its 52-week high.
Key numbers
- Price
- 3,719.00 DKK
- Day change
- +0.57% (21.00)
- Market cap
- 229B DKK
- P/E (trailing)
- 45.9
- P/E (forward)
- 30.7
- Dividend yield
- —
- 50-day average
- 2,457.86
- 200-day average
- 1,972.87
- 52-week range
- 1,512.00 – 3,947.00
- Next earnings
- 5 Nov 2026
Data as of 3 Nov 2026, 16:59 CET. Market data may be delayed.
Genmab A/S over the past year
From daily closing prices. The highest close in the period was 3,912.00 DKK on 30 Oct 2026, the lowest 1,524.00 DKK on 3 Jun 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +64.33% | +97.50% | +113.65% | +82.98% | +96.40% |
| Month | Close (DKK) | Change |
|---|---|---|
| November 2026 | 3,709.00 | -5.19% |
| October 2026 | 3,912.00 | +66.97% |
| September 2026 | 2,343.00 | +10.41% |
| August 2026 | 2,122.00 | +14.18% |
| July 2026 | 1,858.50 | +3.54% |
| June 2026 | 1,795.00 | +5.34% |
| May 2026 | 1,704.00 | +0.83% |
| April 2026 | 1,690.00 | -1.34% |
| March 2026 | 1,713.00 | -7.33% |
| February 2026 | 1,848.50 | -8.58% |
| January 2026 | 2,022.00 | -0.25% |
| December 2025 | 2,027.00 | -0.59% |
Health care peers
Genmab A/S is on the C25 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Novo Nordisk A/S NOVO-B.CO | -0.02% | 1.19T DKK | 10.3 |
| Genmab A/S GMAB.CO | +0.57% | 229B DKK | 45.9 |
| Coloplast A/S COLO-B.CO | +2.97% | 112B DKK | 36.3 |
| Demant A/S DEMANT.CO | -0.97% | 77.1B DKK | 31.9 |
| ALK-Abelló A/S ALK-B.CO | +0.65% | 54.7B DKK | 40.5 |
| Ambu A/S AMBU-B.CO | +0.86% | 21.5B DKK | 42.9 |
| Bavarian Nordic A/S BAVA.CO | -2.71% | 18.2B DKK | 12.5 |
| GN Store Nord A/S GN.CO | +0.71% | 15.6B DKK | — |
| Zealand Pharma A/S ZEAL.CO | +1.17% | 15.5B DKK | 6.1 |
More on GMAB
Open GMAB.CO in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.